Milan Petković
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Milan Petković has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Nikola M. Stojanovic
Centre for Mental Health Protection, University Clinical Centre Niš, 18000 Niš, Serbia
2 shared publications - Andrea Milijic
Center for Mental Health Protection, University Clinical Center Niš, 18000 Niš, Serbia
1 shared publication - Dragana Pavlović
Department of Pharmacy, Faculty of Medicine, University of Nis, Nis, Serbia
1 shared publication - Dušan Sokolović
Department of Biochemistry, Faculty of Medicine, University of Nis, 18000 Nis, Serbia
1 shared publication - Iva Binic
Department of Psychiatry, Faculty of Medicine, University of Niš, 18000 Niš, Serbia
1 shared publication - Ivana Kostić Petrović
Centre for Mental Health Protection, University Clinical Centre Niš, 18000 Niš, Serbia
1 shared publication
Latest Publications
- Open Access
- 30 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (8) , 805
Working Memory Impairment Induced by Chemotherapy—A Narrative Review
Chemotherapy-associated cognitive impairment (CACI) is a common long-term complication of cancer treatment that predominantly affects attention, executive function, information processing, and working memory. Although considerable progress has been made in understanding its molecular basis, the relationship between chemotherapy-induced neurobiological alterations and the functional organization of working memory remains incompletely understood. This narrative review aims to integrate current evidence on the neuroanatomical organization of working memory, the molecular mechanisms underlying CACI, and neuroimaging findings in patients receiving chemotherapy. The review summarizes current knowledge regarding mitochondrial dysfunction, oxidative stress, neuroinflammation, blood–brain barrier disruption, purinergic signaling, and chemotherapy-specific mechanisms of central nervous system injury. Furthermore, the principal mechanisms by which commonly used chemotherapeutic agents reach or indirectly affect the brain are discussed. Clinical neuroimaging findings from selected malignancies are interpreted within the framework of the four-component model of working memory, including the visuospatial sketchpad, phonological loop, central executive, and episodic buffer. Current evidence indicates that chemotherapy induces structural and functional alterations involving the prefrontal cortex, parietal cortex, hippocampus, insula, anterior cingulate cortex, angular gyrus, and associated neural networks. These changes are accompanied by disturbances in executive control, visuospatial processing, verbal working memory, and multimodal information integration. However, considerable heterogeneity among available studies and the difficulty in distinguishing cancer-related from chemotherapy-induced cognitive impairment remain major limitations. By integrating molecular, neuroanatomical, and neuroimaging evidence, this review proposes a conceptual framework linking chemotherapy-induced brain alterations with dysfunction of specific working memory components. Future longitudinal studies combining multimodal neuroimaging, molecular biomarkers, and standardized neuropsychological assessment are needed to identify chemotherapy-specific patterns of cognitive dysfunction and support the development of personalized preventive and therapeutic strategies for cancer survivors.
- 30 July 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (8) , 805
Open AccessWorking Memory Impairment Induced by Chemotherapy—A Narrative Review
Chemotherapy-associated cognitive impairment (CACI) is a common long-term complication of cancer treatment that predominantly affects attention, executive function, information processing, and working memory. Although considerable progress has been made in understanding its molecular basis, the relationship between chemotherapy-induced neurobiological alterations and the functional organization of working memory remains incompletely understood. This narrative review aims to integrate current evidence on the neuroanatomical organization of working memory, the molecular mechanisms underlying CACI, and neuroimaging findings in patients receiving chemotherapy. The review summarizes current knowledge regarding mitochondrial dysfunction, oxidative stress, neuroinflammation, blood–brain barrier disruption, purinergic signaling, and chemotherapy-specific mechanisms of central nervous system injury. Furthermore, the principal mechanisms by which commonly used chemotherapeutic agents reach or indirectly affect the brain are discussed. Clinical neuroimaging findings from selected malignancies are interpreted within the framework of the four-component model of working memory, including the visuospatial sketchpad, phonological loop, central executive, and episodic buffer. Current evidence indicates that chemotherapy induces structural and functional alterations involving the prefrontal cortex, parietal cortex, hippocampus, insula, anterior cingulate cortex, angular gyrus, and associated neural networks. These changes are accompanied by disturbances in executive control, visuospatial processing, verbal working memory, and multimodal information integration. However, considerable heterogeneity among available studies and the difficulty in distinguishing cancer-related from chemotherapy-induced cognitive impairment remain major limitations. By integrating molecular, neuroanatomical, and neuroimaging evidence, this review proposes a conceptual framework linking chemotherapy-induced brain alterations with dysfunction of specific working memory components. Future longitudinal studies combining multimodal neuroimaging, molecular biomarkers, and standardized neuropsychological assessment are needed to identify chemotherapy-specific patterns of cognitive dysfunction and support the development of personalized preventive and therapeutic strategies for cancer survivors.
- Open Access
- 17 December 2025
- Published by University of Nis Faculty of Medicine in AFMN Biomedicine
- Vol. 42 (4) , 464-468
PROTECTIVE EFFECTS OF GREEN TEA AND BILBERRY AGAINST SECONDARY HYPERLIPIDEMIA IN GENTAMICIN‒INDUCED NEPHROTOXICITY IN RATS
The aim of this study was to examine whether green tea and bilberry have beneficial effects on secondary hyperlipidemia developed due to gentamicin-induced renal impairment. GM group of rats was treated with gentamicin only, GT group was given green tea only, B group received bilberry only, while C group was given saline only. GT+GM group received green tea simultaneously with gentamicin, whereas B+GM group was given bilberry with gentamicin. The results showed that gentamicin significantly increased total cholesterol, LDL and triglycerides, while it decreased HDL when compared with the control group. However, when either green tea or bilberry was applied together with gentamicin, this secondary hyperlipidemia was significantly ameliorated, as evidenced by a significant increase of HDL, and a decrease of LDL, cholesterol and triglycerides in comparison to GM group. The beneficial effects of both green tea and bilberry on secondary hyperlipidemia in gentamicin-induced nephrotoxicity occurred due to their powerful antioxidant properties. They are both functional foods, and widely available in nature, and can be used as cost-effective additional therapy together with gentamicin, without affecting its activity in killing bacteria.
- 17 December 2025
- Published by University of Nis Faculty of Medicine in AFMN Biomedicine
- Vol. 42 (4) , 464-468
Open AccessPROTECTIVE EFFECTS OF GREEN TEA AND BILBERRY AGAINST SECONDARY HYPERLIPIDEMIA IN GENTAMICIN‒INDUCED NEPHROTOXICITY IN RATS
The aim of this study was to examine whether green tea and bilberry have beneficial effects on secondary hyperlipidemia developed due to gentamicin-induced renal impairment. GM group of rats was treated with gentamicin only, GT group was given green tea only, B group received bilberry only, while C group was given saline only. GT+GM group received green tea simultaneously with gentamicin, whereas B+GM group was given bilberry with gentamicin. The results showed that gentamicin significantly increased total cholesterol, LDL and triglycerides, while it decreased HDL when compared with the control group. However, when either green tea or bilberry was applied together with gentamicin, this secondary hyperlipidemia was significantly ameliorated, as evidenced by a significant increase of HDL, and a decrease of LDL, cholesterol and triglycerides in comparison to GM group. The beneficial effects of both green tea and bilberry on secondary hyperlipidemia in gentamicin-induced nephrotoxicity occurred due to their powerful antioxidant properties. They are both functional foods, and widely available in nature, and can be used as cost-effective additional therapy together with gentamicin, without affecting its activity in killing bacteria.
- Open Access
- 8 December 2025
- Published by MDPI AG in Psychiatry International
- Vol. 6 (4) , 155
Adverse Childhood Experiences in Patients with Psychotic Disorders: A Single-Centre Study in South-Eastern Serbia
Introduction: Adverse Childhood Experiences (ACEs) refer to traumatic events occurring before the age of 18 that can negatively impact physical and mental health, often disrupting development. Numerous studies have shown associations between ACEs and the onset or severity of psychotic disorders. The aim of this study was to assess the prevalence of ACEs among patients with psychotic disorders and to examine an association between ACEs and the sociodemographic and clinical characteristics of psychosis. Material and Methods: The study was conducted at the Center for Mental Health and the Psychiatric Clinic of the University Clinical Center Nis, from March to July 2025. The sample included adult patients of both sexes diagnosed with psychotic spectrum disorders based on ICD-10 criteria. The Adverse Childhood Experiences Questionnaire (ACE-Q), along with sociodemographic and clinical data from medical records, was used. Results: The sample included 60 patients, with a mean age of 36.7 years. The average ACE-Q score was 2.57 ± 1.98, with one-third of patients reporting high exposure (≥4 ACEs) to childhood adversity. Patients with high ACEs exposure (≥4 ACEs) differed significantly from those with low to moderate or no exposure (<4 ACEs) in terms of economic status, family history of psychiatric disorders, substance use, and treatment adherence. Conclusion: Despite the small sample size, our results point to a potential link between childhood adversity and certain sociodemographic and clinical characteristics in patients with psychotic disorders. Integrating systematic assessments of trauma history into routine clinical practice may support the development of more effective treatment strategies.
- 8 December 2025
- Published by MDPI AG in Psychiatry International
- Vol. 6 (4) , 155
Open AccessAdverse Childhood Experiences in Patients with Psychotic Disorders: A Single-Centre Study in South-Eastern Serbia
Introduction: Adverse Childhood Experiences (ACEs) refer to traumatic events occurring before the age of 18 that can negatively impact physical and mental health, often disrupting development. Numerous studies have shown associations between ACEs and the onset or severity of psychotic disorders. The aim of this study was to assess the prevalence of ACEs among patients with psychotic disorders and to examine an association between ACEs and the sociodemographic and clinical characteristics of psychosis. Material and Methods: The study was conducted at the Center for Mental Health and the Psychiatric Clinic of the University Clinical Center Nis, from March to July 2025. The sample included adult patients of both sexes diagnosed with psychotic spectrum disorders based on ICD-10 criteria. The Adverse Childhood Experiences Questionnaire (ACE-Q), along with sociodemographic and clinical data from medical records, was used. Results: The sample included 60 patients, with a mean age of 36.7 years. The average ACE-Q score was 2.57 ± 1.98, with one-third of patients reporting high exposure (≥4 ACEs) to childhood adversity. Patients with high ACEs exposure (≥4 ACEs) differed significantly from those with low to moderate or no exposure (<4 ACEs) in terms of economic status, family history of psychiatric disorders, substance use, and treatment adherence. Conclusion: Despite the small sample size, our results point to a potential link between childhood adversity and certain sociodemographic and clinical characteristics in patients with psychotic disorders. Integrating systematic assessments of trauma history into routine clinical practice may support the development of more effective treatment strategies.